Webinar: Israeli Companies Targets of US Securities Litigation6월 13, 2017
Federal courts in the United States saw more securities class actions filed in 2016 than in any year since the 1995 passage of the Private Securities Litigation Reform Act (“PSLRA”).1 Although the number of federal securities class actions has risen for several consecutive years, the 41% increase from 2015 to 2016 was unusually sharp, especially amid superior market performance.2 Among many other factors contributing to this trend, claims against foreign issuers listed on US exchanges have become increasingly frequent.3 Israeli companies have proven an especially popular target, accounting for nearly 20% of all such lawsuits against foreign issuers in 2016.
We invite both our US and Israeli colleagues to join us for an upcoming webinar that will provide an overview of core issues and common themes in federal securities class actions, give you an idea of what to expect if your company is named in a securities class action, and present strategies for proactively reducing exposure. RSVP to Rachael Arrott at email@example.com.
1. PwC, 2016 Securities Litigation Study: A rising tide or a rogue wave? (Apr. 2017) at iii, available at http://www.pwc.com/us/en/forensic-services/assets/313021-2017-securities-litigation-2017-v9.pdf.
2. Id. at 4. 2016 was the first year since 2013 (and only the second since the financial crisis of 2007 and 2008) that saw a year-over-year increase in both the number of securities class actions filed and the S&P 500’s aggregate rate of return.
3. Antoinette Gartrell, “Israeli Tech Firms Targeted in More Class Securities Suits,” Bloomberg BNA (Mar. 30, 2017), available at http://news.bna.com/sdln/SDLNWB/split_display.adp?fedfid=108214981&vname= sldbulallissues&jd=a0m1h4x6d8&split=0.
Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.